Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Siddha Flower Essences
WARNING LETTER
•Siddha Flower Essences•April 29, 2025

Siddha Flower Essences – FDA Warning Letter, Apr 29, 2025

Record Details

The FDA issued a Warning Letter to Siddha Flower Essences, LLC., dba Siddha Remedies, following an inspection of its Oxnard, CA drug manufacturing facility from April 22 to 29, 2025. The letter identifies significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals, rendering the company"s human and animal drug products adulterated under the Federal Food, Drug, and Cosmetic Act. Key issues include the failure to adequately test component samples for identity, purity, strength, and quality, and to validate supplier test analyses. Specifically, the company ceased testing purified water after 2022, a critical component for pediatric oral homeopathic drugs, without ensuring its suitability or testing for potential contaminants like Burkholderia cepacia complex (BCC). Inadequate testing of botanical components was also noted. Furthermore, Siddha Flower Essences failed to thoroughly investigate out-of-limit microbiological contamination found in finished drug products, including unidentified gram-negative growth, which poses an unacceptable risk, especially to children. The company also failed to update its drug listings as required by the FD&C Act, leading to misbranded products. The FDA requires a comprehensive, independent review of the company"s material system, including supplier qualification and component testing protocols, and a robust program for investigating contamination and ensuring product quality.

Company
Siddha Flower Essences
Inspection date
April 29, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Dillard H. Woody Jr. (Acting Director)
  • Jill P. Furman (Director)
View Company Profile

ID · c9f87479-b635-4458-a8c2-8695377fd5b2

Violation Codes10
FD&C Act 501(a)(2)(B)21 CFR 211.2221 U.S.C. 360(j)FD&C Act 301(p)FD&C Act 502(o)21 U.S.C. 352(o)21 CFR 207.57(b)(2)21 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 U.S.C. 360(j)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Siddha Flower Essences
  • 483 - 2025-04-29April 29, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Siddha Flower Essences
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.